Asia Pacific is expected to account for the highest CAGR for players operating in the women’s health diagnostics market , F. Hoffmann-La Roche Ltd. Launched the uPath HER2 (4B5) Image Analysis and uPath Dual

Women Health Diagnostic Market Sale to hit US$ 36.6 Billion by 2025 and expand at a CAGR of 7.9%, says MarketsandMarkets™

Data Bridge Market Research analyses that the women's health diagnostics market will exhibit a CAGR of around 7.40% for the forecast period of 2021-2028. Rising prevalence of osteoporosis and other chronic disorders in women, increased focus on research a...